There is widespread consensus on the need for informed consent procedu
res in medical research. Nevertheless, aspects of the informed consent
process remain controversial, and innovative approaches to research m
ay raise new issues and concerns. The randomized consent design for cl
inical trials, proposed by Zelen (N Engl J Med 1979; 300:1242-1245), p
ermitted physicians to randomize patients without consent, then obtain
informed consent from only those patients randomized to the experimen
tal (as opposed to the standard treatment) arm. More recently, the pro
posal has been made to allow waiver of informed consent for study of p
atients in emergency circumstances who may be temporarily incapable of
providing such consent, and for whom no family member is immediately
available to give a ''proxy'' consent (Biros M.H. et al. JAMA 1995; 27
3:1283-1287). The medical community and federal regulatory policy have
responded differently to these proposals. Published by Elsevier Scien
ce Inc. 1997.